Related Experiment Videos
Familial hypercholesterolemia with cholesteryl ester transfer protein deficiency
1Department of Internal Medicine, Hokkaido Central Hospital for Social Health Insurance, Sapporo.
Internal Medicine (Tokyo, Japan)
|July 25, 1998
Summary
This study identified a young male with familial hypercholesterolemia (FH) and cholesteryl ester transfer protein (CETP) deficiency. Genetic analysis confirmed heterozygote status for both conditions, highlighting a complex genetic profile.
Area of Science:
- Genetics
- Cardiovascular Medicine
- Biochemistry
Background:
- Familial hypercholesterolemia (FH) is a genetic disorder characterized by high LDL cholesterol levels, leading to premature cardiovascular disease.
- Cholesteryl ester transfer protein (CETP) plays a role in lipoprotein metabolism and is associated with cardiovascular risk.
- Genetic screening is crucial for diagnosing and understanding complex lipid disorders.
Observation:
- A 21-year-old male presented with clinical signs of hypercholesterolemia, tendon xanthomas, and a family history of early heart disease.
- Genetic analysis of the low-density lipoprotein receptor (LDLR) gene revealed a heterozygous mutation consistent with FH.
- Screening for common Japanese CETP gene mutations identified the patient as a heterozygote for CETP deficiency.
Findings:
- The patient was confirmed to be a heterozygote for familial hypercholesterolemia.
- The patient was also found to be a heterozygote for cholesteryl ester transfer protein deficiency.
- This genetic profile indicates a co-occurrence of two significant mutations impacting atherosclerotic disease risk.
Implications:
- The simultaneous presence of FH and CETP deficiency may accelerate atherosclerosis and increase cardiovascular risk.
- Understanding these combined genetic factors is vital for personalized risk assessment and management strategies.
- Further research into the synergistic effects of these mutations can inform therapeutic interventions for dyslipidemia.